NASDAQ:RNXT
RenovoRx, Inc.
- Stock
Last Close
1.42
17/05 20:00
Market Cap
11.23M
Beta: -
Volume Today
29.06K
Avg: 55.01K
PE Ratio
−1.91
PFCF: −1.75
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
asset turnover | ||||||
cash per share | 0.25 - | 0.21 14.69% | 2.91 1,260.19% | 0.94 67.79% | 0.11 87.85% | |
company equity multiplier | -0.21 - | -0.13 37.14% | 1.06 912.52% | 1.18 11.09% | -0.49 141.45% | |
days of inventory outstanding | ||||||
days of payables outstanding | ||||||
days of sales outstanding | ||||||
dividend yield | ||||||
ebit per revenue | ||||||
ebt per ebit | 0.99 - | 1.19 20.30% | 1.12 5.93% | 0.99 10.88% | 0.90 9.66% | |
effective tax rate | 0.02 - | -0.15 1,041.80% | -0.12 21.02% | 0.01 109.77% | ||
enterprise value multiple | -15.34 - | -19.28 25.72% | -1.76 90.89% | -1.49 15.17% | -1.96 31.82% | |
fixed asset turnover | ||||||
free cash flow per share | -0.40 - | -0.42 5.31% | -1.14 170.18% | -0.97 14.38% | -1.00 2.41% | |
gross profit margin | ||||||
interest coverage | -5.43 - | 6.80 225.21% | -174.56 2,667.17% | -105.52 39.55% | ||
inventory turnover | ||||||
long term debt to capitalization | -0.00 - | |||||
net income per ebt | 0.98 - | 1.15 17.38% | 1.12 2.81% | 0.99 11.94% | 1 1.21% | |
net profit margin | ||||||
operating cash flow per share | -0.40 - | -0.42 5.31% | -1.13 169.49% | -0.97 14.16% | -1.00 2.41% | |
operating profit margin | ||||||
payables turnover | ||||||
pretax profit margin | ||||||
price fair value | -5.57 - | -4.15 25.45% | 1.65 139.61% | 3.45 109.81% | -7.86 327.59% | |
receivables turnover | ||||||
return on assets | -1.66 - | -2.29 37.73% | -0.44 80.98% | -1.34 208.70% | -6.98 418.95% | |
return on capital employed | -2.66 - | 1.47 155.21% | -0.37 125.16% | -1.61 336.97% | -39.16 2,325.65% | |
return on equity | 0.35 - | 0.30 13.43% | -0.46 254.52% | -1.59 242.94% | 3.41 315.13% | |
total debt to capitalization | -0.24 - |
All numbers in USD (except ratios and percentages)